Your Compass for Pharma Success

DESTRUCTION OF HORMONAL SAMPLES LEFT OVER AFTER ANALYSYS

  • PROCEDURE:
  • The left over samples after completion of complete analysis, (including Raw Materials, In- process products, finished products, and Packing Materials) shall be destructed.
  • After completion of the analysis the left over Raw materials, In-Process Powders, tablets, capsules, shall be collected in to double layered poly bag.
  • Finished product samples like Capsules, Tablets shall be opened from the original blisters/Strips packs and only tablets, capsules to be destroyed shall be collected in to a double layered poly bag and de-foiled blisters/ Strips shall be collected in another separate double layered poly bag.
  • The collected left over samples/waste materials shall be dissolved in 4% sodium hypo chloride solution and kept for 48 hours.
  • The executive quality control shall handover the above product waste (Material, Powder, and Tablets & Capsule) to SHE personnel.
  • The SHE personnel dispose the samples as per the SOP
  • The de-foiled Blisters/Strips are collected into polythene bag and send to scrap yard.
  • The Packing materials like Cartons, Labels shall be destroyed by Cutting into pieces, collected in to polythene bag and send to scrap yard.
  • The foils remained after analysis are collected and cut into pieces, collected into polythene Bag and sent to scrap yard.
  • The sample preparation solutions, Stock solutions of standard preparation dissolution waste liquid, Particle size analysis solutions and HPLC drain out liquid shall be collected separate Container.
  • The above collected left over solutions shall be mixed with 4% sodium hypo chloride solution and kept for 48 hours.
  • After completion of detoxification of the solvents shall be sent to the SHE department for further disposable.
Share this article
Shareable URL
Prev Post

CALIBRATION PROCEDURE FOR 8 M HARDNESS TESTERS (DR. SCHLEUNIGER)

Next Post

OPERATION OF LABORATORY INCUBATOR (MAKE: NEWTRONIC)

Leave a Reply

Your email address will not be published. Required fields are marked *

Read next

Discover more from PharmaGuideHub

Subscribe now to keep reading and get access to the full archive.

Continue reading